Investor Relations
Our service to analysts, institutional investors and basic investors helps increase Axxess Pharma's market capitalization and enhances our credibility in the financial markets. Our activities focus on maintaining a comprehensive, consistent and topical dialogue between the company and the financial community.
If you have any questions or would like to be included in our mailing database, please contact:
Daniel Bagi M.D., Treasurer
Toll Free Ph# (888) 276-4723
CA Ph# (416) 410-6006
US Ph# (786) 923-0275
Current Financials
- Axxess Pharma 1Q2016 Earnings Release
- Axxess Pharma 2015 Annual Report
- Axxess Pharma 3Q15 Earnings Release
- 2015 FORM S-1 Registration Statement
- Axxess Pharma 2Q15 Earnings Release
- Axxess Pharma 1Q15 Earnings Release
- Axxess Pharma 2014 Annual Report
- Axxess Pharma 3Q14 Earnings Release
- Axxess Pharma 2Q14 Earnings Release
- Axxess Pharma 2014 Form S-1 Registration
- Axxess Pharma 1Q14 Earnings Release
- Axxess Pharma 2013 Annual Report
- Axxess Pharma 3Q13 Earnings Release
- Axxess Pharma 2Q13 Earnings Release
- Axxess Pharma 1Q13 Earnings Release
- Axxess Pharma 2012 Annual Report
Quick Links
http://www.axxesspharmainc.com/axxess_tapout.php
Investor Information
For further information, please contact:
Daniel Bagi M.D., Treasurer
Toll Free Ph# (888) 276-4723
CA Ph# (416) 410-6006
US Ph# (786) 923-0275
Follow Axxess